3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one

C138H192N34O7 — CID 157064031

IUPAC3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one
SMILESCC1CN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.CCN(CC)CC1CCCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.C[C@@H]1CCCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.Cn1ncnc1C1CCCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CC(c2ccccc2)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCCC(Oc2ccccc2)C1
InChIInChI=1S/C26H33N5O2.C25H40N6O.C24H29N5O.C23H32N8O.C21H31N5O.C19H27N5O/c32-24(31-17-7-12-21(18-31)33-20-10-5-2-6-11-20)14-13-22-25-23(30-29-22)15-16-27-26(25)28-19-8-3-1-4-9-19;1-3-30(4-2)17-19-9-8-16-31(18-19)23(32)13-12-21-24-22(29-28-21)14-15-26-25(24)27-20-10-6-5-7-11-20;30-22(29-15-18(16-29)17-7-3-1-4-8-17)12-11-20-23-21(28-27-20)13-14-25-24(23)26-19-9-5-2-6-10-19;1-30-23(25-15-26-30)16-6-5-13-31(14-16)20(32)10-9-18-21-19(29-28-18)11-12-24-22(21)27-17-7-3-2-4-8-17;1-15-6-5-13-26(14-15)19(27)10-9-17-20-18(25-24-17)11-12-22-21(20)23-16-7-3-2-4-8-16;1-13-11-24(12-13)17(25)8-7-15-18-16(23-22-15)9-10-20-19(18)21-14-5-3-2-4-6-14/h2,5-6,10-11,15-16,19,21H,1,3-4,7-9,12-14,17-18H2,(H,27,28)(H,29,30);14-15,19-20H,3-13,16-18H2,1-2H3,(H,26,27)(H,28,29);1,3-4,7-8,13-14,18-19H,2,5-6,9-12,15-16H2,(H,25,26)(H,27,28);11-12,15-17H,2-10,13-14H2,1H3,(H,24,27)(H,28,29);11-12,15-16H,2-10,13-14H2,1H3,(H,22,23)(H,24,25);9-10,13-14H,2-8,11-12H2,1H3,(H,20,21)(H,22,23)/t;;;;15-;/m....1./s1
InChIKeyABQWGALUZCUXAR-XCQWXCOUSA-N
MW2439.28 g/mol
LogP23.36
Rot. Bonds38

About 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one

3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one (PubChem CID 157064031) has the molecular formula C138H192N34O7 and a molecular weight of 2439.28 g/mol. Its IUPAC name is 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one.

Molecular Properties

Compound Name3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one
PubChem CID157064031
Molecular FormulaC138H192N34O7
Molecular Weight2439.28 g/mol
Exact Mass2437.57
IUPAC Name3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one
SMILESCC1CN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.CCN(CC)CC1CCCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.C[C@@H]1CCCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.Cn1ncnc1C1CCCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CC(c2ccccc2)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCCC(Oc2ccccc2)C1
InChIInChI=1S/C26H33N5O2.C25H40N6O.C24H29N5O.C23H32N8O.C21H31N5O.C19H27N5O/c32-24(31-17-7-12-21(18-31)33-20-10-5-2-6-11-20)14-13-22-25-23(30-29-22)15-16-27-26(25)28-19-8-3-1-4-9-19;1-3-30(4-2)17-19-9-8-16-31(18-19)23(32)13-12-21-24-22(29-28-21)14-15-26-25(24)27-20-10-6-5-7-11-20;30-22(29-15-18(16-29)17-7-3-1-4-8-17)12-11-20-23-21(28-27-20)13-14-25-24(23)26-19-9-5-2-6-10-19;1-30-23(25-15-26-30)16-6-5-13-31(14-16)20(32)10-9-18-21-19(29-28-18)11-12-24-22(21)27-17-7-3-2-4-8-17;1-15-6-5-13-26(14-15)19(27)10-9-17-20-18(25-24-17)11-12-22-21(20)23-16-7-3-2-4-8-16;1-13-11-24(12-13)17(25)8-7-15-18-16(23-22-15)9-10-20-19(18)21-14-5-3-2-4-6-14/h2,5-6,10-11,15-16,19,21H,1,3-4,7-9,12-14,17-18H2,(H,27,28)(H,29,30);14-15,19-20H,3-13,16-18H2,1-2H3,(H,26,27)(H,28,29);1,3-4,7-8,13-14,18-19H,2,5-6,9-12,15-16H2,(H,25,26)(H,27,28);11-12,15-17H,2-10,13-14H2,1H3,(H,24,27)(H,28,29);11-12,15-16H,2-10,13-14H2,1H3,(H,22,23)(H,24,25);9-10,13-14H,2-8,11-12H2,1H3,(H,20,21)(H,22,23)/t;;;;15-;/m....1./s1
InChIKeyABQWGALUZCUXAR-XCQWXCOUSA-N
XLogP23.36
TPSA486.64 Ų
H-Bond Donors12
H-Bond Acceptors29
Rotatable Bonds38
Heavy Atoms179
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002439.28
LogP ≤ 523.36
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1029

Analyze 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-cyclohexyl-N-[5-[3-[4-[3-fluoro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-1H-pyrrolo[3,2-c]pyridin-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]acetamide
CID 137145389
N-[5-[3-[4-[3-fluoro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-1H-pyrrolo[3,2-c]pyridin-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]cyclohexanecarboxamide
CID 137310751
2-[3-[6-[4-[2-[3-[6-[2-[[2-[3-[5-fluoro-4-(1H-indazol-5-ylamino)pyrrolo[2,1-f][1,2,4]triazin-2-yl]phenoxy]acetyl]amino]propyl]-4-(1H-indazol-5-ylamino)pyrrolo[2,1-f][1,2,4]triazin-2-yl]phenoxy]acetyl]morpholin-2-yl]-4-[4-(1H-pyrazol-4-yl)anilino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]phenoxy]-N-propan-2-ylacetamide
CID 155227879
5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-(2-methylpyrimidin-5-yl)-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-(5-phenoxy-3-pyridinyl)-N-pyridin-4-yl-1H-indazole-3-carboxamide
CID 157102765
3-[4-(3,4-dimethylpyrrolidin-1-yl)pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-[4-[3-(phenoxymethyl)pyrrolidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-[4-(3-phenylpyrrolidin-1-yl)pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-[4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)piperazin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;1-[[1-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]pyrrolidin-3-yl]methyl]pyrrolidin-2-one
CID 157242551
N-cyclohexyl-N-methyl-4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]benzamide;N-cyclopentyl-4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]benzamide;(4,4-difluoropiperidin-1-yl)-[4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]methanone;N-(2-methoxyethyl)-4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]benzamide;(4-methoxyphenyl)-[4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]cyclohexyl]methanone;N-methyl-4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]-N-phenylbenzamide
CID 157550007
N-cyclohexyl-N-methyl-4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]benzamide;N-cyclopentyl-4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]benzamide;(4,4-difluoropiperidin-1-yl)-[4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]methanone;N-(2-methoxyethyl)-4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]benzamide;N-(2-methoxyphenyl)-4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]benzamide;N-methyl-4-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]-N-phenylbenzamide
CID 158017550
5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-[6-(dimethylamino)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-N-[6-(dimethylamino)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-[6-[2-(dimethylamino)ethylamino]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(dimethylamino)-3-pyridinyl]-5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(dimethylamino)-3-pyridinyl]-5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(dimethylamino)-3-pyridinyl]-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-[6-(dimethylamino)-3-pyridinyl]-5-(5-phenoxy-3-pyridinyl)-1H-indazole-3-carboxamide;N-[6-(dimethylamino)-3-pyridinyl]-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
CID 158395904
5-(5-amino-3-pyridinyl)-N-[6-(azetidin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(azetidin-1-yl)-3-pyridinyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-(6-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide;methane;N-(6-morpholin-4-yl-3-pyridinyl)-5-(5-phenoxy-3-pyridinyl)-1H-indazole-3-carboxamide
CID 158543637
5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-(6-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-[6-(azetidin-1-yl)-3-pyridinyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-(6-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-morpholin-4-yl-3-pyridinyl)-5-(5-phenoxy-3-pyridinyl)-1H-indazole-3-carboxamide
CID 158907506
CID 159096803
CID 159096803
2-cyclopropyl-7-[4-(5-propan-2-yloxy-1H-indazol-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;3-[2-(3,3-difluorocyclobutyl)-4-pyridinyl]-5-propan-2-yloxy-1H-indazole;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-ethoxy-1H-isoindole;4-[4-(6-ethoxy-3H-isoindol-1-yl)-2-pyridinyl]-1-methylpiperazin-2-one;2-methyl-5-[1-[4-(5-propan-2-yloxy-1H-indazol-3-yl)-2-pyridinyl]piperidin-4-yl]-1,3,4-oxadiazole
CID 159417816

Frequently Asked Questions

What is the IUPAC name of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one?
The IUPAC name of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one (CID 157064031) is 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one.
What is the SMILES notation for 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one?
The canonical SMILES for 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one is CC1CN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.CCN(CC)CC1CCCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.C[C@@H]1CCCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.Cn1ncnc1C1CCCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CC(c2ccccc2)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCCC(Oc2ccccc2)C1.
What is the InChIKey of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one?
The InChIKey is ABQWGALUZCUXAR-XCQWXCOUSA-N. The full InChI is InChI=1S/C26H33N5O2.C25H40N6O.C24H29N5O.C23H32N8O.C21H31N5O.C19H27N5O/c32-24(31-17-7-12-21(18-31)33-20-10-5-2-6-11-20)14-13-22-25-23(30-29-22)15-16-27-26(25)28-19-8-3-1-4-9-19;1-3-30(4-2)17-19-9-8-16-31(18-19)23(32)13-12-21-24-22(29-28-21)14-15-26-25(24)27-20-10-6-5-7-11-20;30-22(29-15-18(16-29)17-7-3-1-4-8-17)12-11-20-23-21(28-27-20)13-14-25-24(23)26-19-9-5-2-6-10-19;1-30-23(25-15-26-30)16-6-5-13-31(14-16)20(32)10-9-18-21-19(29-28-18)11-12-24-22(21)27-17-7-3-2-4-8-17;1-15-6-5-13-26(14-15)19(27)10-9-17-20-18(25-24-17)11-12-22-21(20)23-16-7-3-2-4-8-16;1-13-11-24(12-13)17(25)8-7-15-18-16(23-22-15)9-10-20-19(18)21-14-5-3-2-4-6-14/h2,5-6,10-11,15-16,19,21H,1,3-4,7-9,12-14,17-18H2,(H,27,28)(H,29,30);14-15,19-20H,3-13,16-18H2,1-2H3,(H,26,27)(H,28,29);1,3-4,7-8,13-14,18-19H,2,5-6,9-12,15-16H2,(H,25,26)(H,27,28);11-12,15-17H,2-10,13-14H2,1H3,(H,24,27)(H,28,29);11-12,15-16H,2-10,13-14H2,1H3,(H,22,23)(H,24,25);9-10,13-14H,2-8,11-12H2,1H3,(H,20,21)(H,22,23)/t;;;;15-;/m....1./s1.
What are the key properties of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one?
3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one has a molecular weight of 2439.28 g/mol, XLogP of 23.36, 38 rotatable bonds, 12 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(diethylaminomethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-methylazetidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-methylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(2-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenoxypiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylazetidin-1-yl)propan-1-one is sourced from PubChem (CID 157064031), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).